Contraceptive Pills Market Size
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 9.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Contraceptive Pills Market Analysis
The contraceptive pills market is poised to register a CAGR of 9% during the forecast period.
The COVID-19 pandemic had a substantial impact on the contraceptive pills market. Several guidelines are being introduced about contraceptive pills that have benefitted the market during the COVID-19 pandemic. For instance, according to the guidelines by MoHFW published in October 2021 by the government of India, oral contraceptive pills should be freely available in all public health facilities (including the COVID care facilities). According to the same source, extra packets (at least two months' supply) of oral contraceptive pills can be handed over to repeat clients to avoid multiple contacts. Thus, the demand for contraceptive pills remained significant during the pandemic.
However, with the introduction of vaccines, government authorities and healthcare organizations have recommended reducing the consumption of contraceptive pills before administering vaccines. For instance, according to an April 2021 update by the Taiwan Centers for Disease Control, the Advisory Committee on Immunization Practices (ACIP), the ACIP made a resolution to add related reminding messages on the notice of "precautions to take before COVID-19 vaccination with AstraZeneca vaccine." Taking contraceptive pills and undergoing hormone therapy are risk factors for blood clotting, thus, people receiving these treatments are advised to pause the process at least 28 days before and after inoculation at this stage. Hence, the COVID-19 pandemic had a significant impact on the market initially. However, as the pandemic subsided, the market is expected to have a stable growth during the forecast period.
Furthermore, the increasing rate of unintended pregnancies is a major factor driving the demand for contraceptive pills, thereby contributing to the market growth. For instance, according to a March 2021 update by the United Nations Populations Fund, the number of unintended pregnancies was 1.4 million across 115 low- and middle-income countries. Thus, such statistics indicate the increasing demand for contraceptive pills across the globe, thereby contributing to the market growth.
Additonally, various initiatives taken by governments worldwide is also expected to boost the market growth. For instance, according to the Council of Ministers of Spain in May 2022, the Spainish government reformed the law regarding sexual and reproductive health and the voluntary interruption of pregnancy. New measures on sexuality education and contraception, menstrual health, pregnancy, childbirth, abortion, and reproductive violence was taken. It was also mentioned that the morning-after contraceptive pill will be made available free of charge in health centres and future public centres specialising in sexual and reproductive rights, and must be available in all pharmacies.
Moreover, several developments by key market players are expected to further boost the market growth. For instance, in April 2021, Mayne Pharma reported that the US FDA had approved NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens.
Therefore, owing to the abovementioned factors, the market studied is anticipated to witness growth over the forecast period. However, side effects associated with the use of contraceptive drugs and increased usage of alternative birth control methods are the factors expected to hinder market growth over the forecast period.
Contraceptive Pills Market Trends
This section covers the major market trends shaping the Contraceptive Pills Market according to our research experts:
The Generic Segment is Expected to Hold a Significant Share of the Market Over the Forecast Period
By category, the generic segment is expected to witness significant growth. The generic segment has the largest share in the market due to the widespread adoption of generic contraceptives, owing to their low prices and market availability. For instance, in February 2022, Asda lowered the price of its generic emergency hormonal contraception (EHC) pill to GBP 9.89 (USD 13.33) to ensure it is more accessible to women in the United Kingdom.
Furthermore, the increasing need for population control and the rising incidence of abortion has driven the growth of generic contraceptive pills in the market. Thus, several market players are engaged in implementing strategic initiatives, thereby boosting market growth. For instance, in March 2021, Mayne Pharma Group Limited commercially launched a generic version of ORTHO-CEPT (desogestrel and Ethinyl estradiol 0.15 mg/0.03 mg) tablets to customers in the United States. Such developments are likely to positively impact the adoption of generic contraceptive pills among women.
Hence, due to the abovementioned factors, the segment is expected to witness significant growth during the forecast period.
North America is Expected to Hold the Largest Share in the Market
Within North America, the US holds a major share of the market owing to rapid developments in the healthcare infrastructure and high awareness about contraceptive pills in the region. For instance, according to the data published by NCBI in September 2022, the birth control contraception pill is the most commonly prescribed form of contraception in the United States, and approximately 25% of women aged 15 to 44 who currently use contraception reported using the pill as their method of choice; the most commonly prescribed pill was found to be the combined hormonal pill with estrogen and progesterone. Thus, the consumption of contraceptive pills in the United States is significant and is expected to continue over the forecast period.
Several organizations are also engaged in implementing strategic initiatives in the country. For instance, as per the Bill & Melinda Gates Foundation data published in 2022, the foundation is aiming to offer USD 280 million per year from 2021 to 2030 for developing new and improved contraceptive technologies, support family planning programs that reflect the preferences of local communities, and enable women and girls to be in control of their contraceptive care. Such developments are anticipated to boost the adoption of oral contraceptive pills in the country, thereby boosting the market growth.
Hence, due to the abovementioned factors, the market is expected to witness significant growth over the forecast period.
Contraceptive Pills Industry Overview
The contraceptive pills market is moderately consolidated in nature due to the presence of a few companies operating globally and regionally. The competition in the market is set to intensify as several key players are focusing on the expansion of their product portfolios through acquisitions and collaborations. The contraceptive pills market is expected to open up several opportunities for the new players, as well as the currently established market leaders. The key players in the market include Bayer AG, Amneal Pharmaceuticals LLC, Pfizer Inc., Mayne Pharma, and Teva Pharmaceuticals, among others.
Contraceptive Pills Market Leaders
-
Teva Pharmaceuticals
-
Bayer AG
-
Pfizer Inc.
-
Amneal Pharmaceuticals LLC
-
Mayne Pharma
*Disclaimer: Major Players sorted in no particular order
Contraceptive Pills Market News
- November 2022: Lupin Limited announced that they had received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA), Drospirenone Tablets, 4 mg (a contraceptive pill), to market a generic equivalent of Slynd Tablets, 4 mg, of Exeltis USA Inc.
- October 2022: Hungary-based Gedeon Richter announced the launch of Drovelis (estetrol (E4]/ drospirenone (DRSP)) as a combined oral contraceptive in the United Kingdom.
- February 2022: Organon acquired rights from Bayer AG to Marvelon and Mercilon, combined oral hormonal daily contraceptive pills, in the People's Republic of China, including Hong Kong and Macau, and entered into an agreement to acquire the rights to these products in Vietnam.
Contraceptive Pills Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Rate of Unintended Pregnancies
- 4.2.2 Growing Awareness about Contraceptive Pills and Ease of Use and Low Cost
-
4.3 Market Restraints
- 4.3.1 Side Effects Associated with the Use of Contraceptive Drugs
- 4.3.2 Increased Usage of Alternative Birth Control Methods
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value- USD million)
-
5.1 By Hormone Type
- 5.1.1 Progestin Pills
- 5.1.2 Combination Pills
- 5.1.2.1 Monophasic
- 5.1.2.2 Triphasic
- 5.1.2.3 Other Combination Pills
-
5.2 By Category
- 5.2.1 Generic
- 5.2.2 Branded
-
5.3 By Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Bayer AG
- 6.1.2 Amneal Pharmaceuticals LLC
- 6.1.3 Teva Pharmaceuticals
- 6.1.4 Abbvie Inc. (Allergan PLC)
- 6.1.5 Pfizer Inc.
- 6.1.6 Johnson & Johnson
- 6.1.7 Aurobindo Pharma Limited
- 6.1.8 Organon International (Merck & Co. Inc.)
- 6.1.9 Sanofi SA
- 6.1.10 Mayne Pharma
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityContraceptive Pills Industry Segmentation
According to the scope of the report, a contraceptive pill is a kind of medicine with hormones, which generally comes in a pack and has proven to be a useful family planning tool, offering reliable access to birth-rate management.
The contraceptive pills market is expected to grow at a CAGR of 9% during the forecast period. The market is segmented by Hormone Type (Progestin Pills, Combination Pills (Monophasic, Triphasic, Other Combination Pills)), Category (Generic, Branded), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the market sizes and forecasts in terms of value in USD million for the above segments.
| By Hormone Type | Progestin Pills | |
| Combination Pills | Monophasic | |
| Triphasic | ||
| Other Combination Pills | ||
| By Category | Generic | |
| Branded | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Contraceptive Pills Market Research FAQs
What is the current Contraceptive Pills Market size?
The Contraceptive Pills Market is projected to register a CAGR of 9% during the forecast period (2024-2029)
Who are the key players in Contraceptive Pills Market?
Teva Pharmaceuticals, Bayer AG, Pfizer Inc., Amneal Pharmaceuticals LLC and Mayne Pharma are the major companies operating in the Contraceptive Pills Market.
Which is the fastest growing region in Contraceptive Pills Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Contraceptive Pills Market?
In 2024, the North America accounts for the largest market share in Contraceptive Pills Market.
What years does this Contraceptive Pills Market cover?
The report covers the Contraceptive Pills Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Contraceptive Pills Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Contraceptive Pills Industry Report
Statistics for the 2024 Contraceptive Pills market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Contraceptive Pills analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
